drugset / Trial / NCT03057574

Gonapure® in Multifollicular Stimulation in Egyptian Women Undergoing IVF/ICSI

NCT03057574

Phase 4 Unknown 200 enrolled MinaPharm Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

This study aims to record Efficacy, Safety and tolerability of Gonapure® prescribed for female subjects with infertility Undergoing IVF/ICSI

Timeline

Start
2017-02-09
Primary completion
2017-12
Completion
2018-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Gonal-f Protein / enzyme biologic 75 iu Intramuscular
Subject Gonal-f Protein / enzyme biologic 450 iu Intramuscular

Indications